, suggesting that water con tent should follow similar trends. This enigma can be solved if water is not the primary cause of seismic attenuation, as shown by Cline and colleagues.
Nevertheless, there are some issues regard ing the applicability of Cline and colleagues' results to the actual mantle. For instance, the authors artificially increased the water content of some of their olivine aggregates using a tech nique called doping, in which a trace amount of one element is substituted for another. This process introduced artificial crystal defects whose mobility might differ from the defects intrinsic to olivine -although the authors argue that these artificial defects do not affect their conclusions. The effect of oxygen fugac ity on the mobility of these different types of defect is also unknown.
Future studies on the seismic properties of olivine could avoid the need for doping by subjecting aggregates to higher pressures than those used by Cline and colleagues. For example, measurements could be made using an oscillation technique that combines a large volume press and Xray observations 17 . Future experiments should include wider ranges of oxidation conditions and olivine grain sizes than those considered by Cline et al., to con firm the dominance of oxygen fugacity over other causes of anelastic behaviour.
Although some petrological evidence suggests that oxygen fugacity in the mantle generally decreases with depth 12, 13 , it has been difficult to evaluate how such oxidation states vary laterally. The probable link between oxy gen fugacity and attenuation of seismic waves in peridotite could enable 3D mapping of oxi dation states in the deep mantle, using data obtained with an imaging technique called seismic tomography. Meanwhile, the lack of correlation between water content in mantle olivine and seismic attenuation, if confirmed by independent studies at higher pressures, might require scientists to reconsider the role of water in the softening of mantle rocks, and the distribution and circulation of water throughout the deep Earth. ■ 
Tetsuo Irifune and
ick up any article on neuronal development in adulthood, and there is a good chance you will read that the birth of new neurons has been observed in the hippo campal region of the brain in every mammalian species examined, including humans. This idea underlies the view -wide spread among neuroscientists -that analysis of such neurogenesis in animals can benefit our understanding of learning, emotional disorders and neurodegenerative disease in humans. But Sorrells et al. 1 report on page 377 that, unlike in other mammals, the last new neurons in the human hippo campus are gener ated in childhood. These findings are certain to stir up controversy.
Today, it is common knowledge that the brain can change according to needs and demands. But it was not always so. In the 1960s, biologist Joseph Altman reported that new neurons are generated in the adult brain, specifically in a hippocampal subregion called the dentate gyrus, which is now known to be crucial for memory 2 . Further research languished, however, owing to scepticism about the brain's capacity for such dramatic plasticity. It wasn't until the 1990s, with the development of improved techniques for visualizing brain cells, that acceptance of adult neurogenesis became widespread 3 .
Although the scope and function of neuro genesis remain debatable, there has been a general consensus that the hippocampus is one region in which adult neurogenesis exists in humans as it does in animals. This is based on several studies. For example, one study in patients given a synthetic nucleoside molecule called bromodeoxyuridine (BrdU) showed that it had been incorporated into the DNA of divid ing cells in the dentate gyrus 4 . Another found that protein markers of neurogenesis in animals were present in postmortem human brain tissue 5 , and a third used radiocarbon dating to identify hippocampalneuron turn over 6 . How ever, methodological challenges make human studies difficult to interpret, and more are required to make definitive conclusions.
Sorrells et al. set out to address this need using classic immunohistochemical techniques in which specific antibodies are bound to pro teins of interest, revealing their locations in tissue. The authors used this strategy to count neural precursor cells, proliferating cells and immature neurons in samples from 59 human subjects, spanning fetal development through to old age (Fig. 1) . They found streams of all three cell types migrating from an embryonic 'germinal zone' to the developing dentate gyrus at 14 weeks of gestation. By 22 weeks, migra tion was reduced, and immature neurons were largely restricted to the dentate gyrus. And there were many fewer immature neurons at one year of life than at earlier stages. The oldest sample containing immature neurons was taken from a 13yearold individual. These findings are in stark contrast to the prevailing view that human hippocampal neurogenesis extends throughout adult life.
Is it possible to reconcile the findings with previous human data? Although direct com parisons are difficult, Sorrells et al. offer some explanations. For example, they find that DCX and PSANCAM, two proteins that reliably mark immature neurons in animals, can label mature neurons and nonneuronal glial cells in humans. Indeed, the authors show that these two markers unambiguously identify imma ture neurons only if both are expressed in a
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Questioning human neurogenesis
Neurons are born in the brain's hippocampus throughout adulthood in mammals, contributing to the region's functions in memory and mood. But a study now questions whether this phenomenon really extends to humans. See Letter p.377 cell. Similarly, the group demonstrated that it is possible to obtain BrdUlike immuno histochemical labelling in tissue that did not actually contain BrdU. Nonspecific labelling could therefore have led to falsepositive results in previous studies.
The researchers' careful approach also speaks to the challenges of performing neuro genesis work in humans. Animal studies have shown that PSANCAM is modified by previ ous experiences 7 and that DCX degrades if tis sue is not rapidly preserved 8 . An apparent loss of neurogenesis could therefore reflect changes in marker expression, especially if stringent criteria are used to define new neurons. Given that there are debates about hippocampal pre cursorcell identity even in rodents 9 , it is also possible that we simply do not know what to look for in humans.
Sorrells et al. minimized these issues in several ways. First, they observed neurogenesis in the hippocampus of infants and children, which served as a positive control. Second, they used a variety of adult samples to mini mize the possibility that problems with tissue health or preservation could confound their results. Third, they used diverse markers of neurogenesis to gain multiple lines of evidence. Nonetheless, further investigation will be needed to see whether Sorrells and colleagues' conclusions will stand the test of time.
How do the authors' findings fit with the animal literature? With a bit of conceptual recalibration, they might fit quite well. Rodents are born with relatively immature nervous sys tems, so adult rodent neurogenesis could be a decent model of neurogenesis in children or adolescents. Given that depression, schizo phrenia and Alzheimer's disease are rooted in early hippocampal defects, even neurons generated in childhood could have a key role in the aetiology of disease in humans. In addi tion, primate data 10 suggest that new neurons in humans could go through an extended period of maturation (years or even decades)
P R AT I T I B A N D O PA D H AYAY & M AT T H E W M E Y E R S O N
T he mapping of the human genome, followed by the explosion in next generation genome sequencing, has revolutionized our understanding of cancer. These advances have paved the way for pre cisionmedicine approaches to treating adult cancers. Two papers in Nature report the first pancancer genomic analyses in children. In the first, Gröbner et al. 1 (page 321) analysed sequences of whole exomes (all the protein coding regions in the genome) or whole genomes for 961 cancers across 24 tumour types, with an emphasis on tumours of the central nervous system. In the second, Ma et al. 2 (page 371) used similar analyses to characterize 1,699 cancers across 6 types of cancer tissue, particularly leukaemias.
CANCER GENOMICS
Landscapes of childhood tumours
Two analyses of the genetic alterations that characterize paediatric cancers reveal key differences from adult cancers, and point to ways of optimizing therapeutic approaches to combating cancer in children. See Article p.321 & Letter p.371 relative to what occurs in rodents, during which time they might have enhanced plastic ity and important functional properties. Thus, whereas the continual addition of new neurons might provide plasticity in adult rodents, the prolonged development of neurons could pro vide a similar plasticity in adult humans.
At the other end of the developmental spectrum, even in rodents, neurogenesis is very low by middle age 2 . Thus, Sorrells and colleagues' human data again are not wholly inconsistent with the animal literature. If the focus of rodent studies were shifted to identifying the mechanisms by which neuro genesis diminishes over time, and to how neurogenesis can be enhanced to offset pathol ogy caused by age and disease, we just might be able to translate the authors' sobering findings into discoveries that improve human health. ■ 
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